Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Dec 10, 2018 (8 years ago)

Monsel's (Ferric Subsulfate)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Superpotent Drug: contains higher levels of Iron than labeled.

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Monsel's (Ferric Subsulfate) Solution, 8 mL amber glass bottle, packaged as one dozen bottles with applicators per box, Rx only, Gordon Laboratories, Upper Darby, PA 19082, NDC 10481-0112-8.

Affected NDC 10481-0112-08

Compare with the code on your package — it is the most precise check available.

Recalling firm
Gordon Laboratories
NDC code
10481-0112-8
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0338-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other wrong potency / content recalls from 2018

All wrong potency / content recalls
Class II · Moderate risk

Nitrofurantoin Oral Suspension

Subpotent Drug: Expansion of June 2018 recall of lots S700065 and S700619 due to below specification results for assay.

Terminated Wrong potency / content Lupin Somerset NDC 43386-450-11 D-0346-2019
Class III · Low risk

Absorica (Isotretinoin)

Subpotent Drug: Isotretinoin content results were lower than the specification limit obtained during routing product monitoring.

Terminated Wrong potency / content Sun Pharmaceutical Industries, Inc. NDC 10631-117-31 D-1207-2019